Dr. Lisa Keefe, Executive Director of the IMCA-CAT, our HWI operated facility outside of Chicago, has been named a 2023 recipient of the Impact Argonne Award. The honor, awarded annually, recognizes notable achievements in one of the following areas while modeling Argonne Core Values: Innovation, Discovery, Extraordinary Effort, Program Development, Enhancement of Argonne and/or Professional Reputation, Safety and Security Results, Diversity and Inclusion Results, and Significant Cost Reduction. Dr. Keefe was among a group of eight individuals who received the award for Enhancement of Argonne’s Reputation by leading VIP tours throughout 2022. The VIP tours led by Dr. Keefe were in part due to the tremendous contributions and impact IMCA-CAT had on the COVID-19 pandemic.
Congratulations, Lisa, on this notable achievement!
IMCA-CAT is a structural biology research facility for pharmaceutical drug discovery programs. It was established in 1992 to design, build, and operate a research facility at the Advanced Photon Source, a high energy synchrotron X-ray source at Argonne National Laboratory. Today, IMCA-CAT operates a state-of-the-art insertion device beamline for confidential and proprietary macromolecular crystallography experiments. To meet the demands of the pharmaceutical industry, IMCA-CAT is optimized for high-throughput data acquisition, is committed to generating the highest quality X-ray diffraction data, provides reliable access for proprietary research, ensures maximum efficiency, and invests in the facility to remain at the technical forefront for pharmaceutical research in structural biology.
Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.